| Primary |
| Local Anaesthesia |
23.7% |
| Anaesthesia |
12.4% |
| Hypertension |
6.2% |
| Product Used For Unknown Indication |
5.6% |
| Drug Use For Unknown Indication |
5.1% |
| Osteoarthritis |
5.1% |
| Blepharoplasty |
4.5% |
| Occipital Neuralgia |
4.0% |
| Pain |
4.0% |
| Cardiac Failure Congestive |
3.4% |
| Rotator Cuff Syndrome |
3.4% |
| Back Pain |
2.8% |
| Nerve Block |
2.8% |
| Premedication |
2.8% |
| Ventricular Tachycardia |
2.8% |
| Analgesic Therapy |
2.3% |
| Bursitis |
2.3% |
| Cellulite |
2.3% |
| Convulsion |
2.3% |
| General Anaesthesia |
2.3% |
|
| Drug Hypersensitivity |
14.8% |
| Toxicity To Various Agents |
9.9% |
| Rash |
7.4% |
| Bronchospasm |
6.2% |
| Hypertension |
4.9% |
| Hypoaesthesia |
4.9% |
| Methaemoglobinaemia |
4.9% |
| Overdose |
4.9% |
| Ventricular Tachycardia |
4.9% |
| Wrong Technique In Drug Usage Process |
4.9% |
| Anaphylactic Reaction |
3.7% |
| Anaphylactic Shock |
3.7% |
| Drug Ineffective |
3.7% |
| Dysarthria |
3.7% |
| Respiratory Arrest |
3.7% |
| Toxic Anterior Segment Syndrome |
3.7% |
| Arthritis Bacterial |
2.5% |
| Blood Pressure Increased |
2.5% |
| Cardiac Arrest |
2.5% |
| Death |
2.5% |
|
| Secondary |
| Product Used For Unknown Indication |
25.9% |
| Anaesthesia |
10.8% |
| Hypertension |
7.6% |
| Epidural Analgesia |
7.2% |
| General Anaesthesia |
6.0% |
| Cardiac Failure Congestive |
4.8% |
| Induction Of Anaesthesia |
4.0% |
| Local Anaesthesia |
4.0% |
| Convulsion |
3.6% |
| Nerve Block |
3.6% |
| Epidural Anaesthesia |
3.2% |
| Anaesthesia Procedure |
2.4% |
| Herpes Zoster |
2.4% |
| Pain |
2.4% |
| Prophylaxis |
2.4% |
| Arthralgia |
2.0% |
| Maternal Exposure During Pregnancy |
2.0% |
| Premedication |
2.0% |
| Sedative Therapy |
2.0% |
| Ventricular Arrhythmia |
2.0% |
|
| Toxicity To Various Agents |
13.0% |
| Drug Hypersensitivity |
10.9% |
| Respiratory Arrest |
8.7% |
| Urticaria |
8.7% |
| Presyncope |
6.5% |
| Drug Toxicity |
4.3% |
| Headache |
4.3% |
| Incorrect Route Of Drug Administration |
4.3% |
| Osteomyelitis |
4.3% |
| Pulmonary Embolism |
4.3% |
| Tracheostomy |
4.3% |
| Tremor |
4.3% |
| Unevaluable Event |
4.3% |
| Vomiting |
4.3% |
| Alopecia |
2.2% |
| Arterial Occlusive Disease |
2.2% |
| Arthralgia |
2.2% |
| Bacterial Infection |
2.2% |
| Blister |
2.2% |
| Cardiac Arrest |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
43.4% |
| Multiple Myeloma |
7.3% |
| Fabry's Disease |
5.1% |
| Constipation |
4.6% |
| Spinal Operation |
4.2% |
| Graft Versus Host Disease |
3.5% |
| Infection Prophylaxis |
3.5% |
| Prophylaxis |
3.0% |
| Back Pain |
2.9% |
| Hypertension |
2.9% |
| Pain |
2.5% |
| Hypokalaemia |
2.2% |
| Acute Graft Versus Host Disease |
2.0% |
| Analgesic Therapy |
1.9% |
| Cardiac Failure |
1.9% |
| Prostate Cancer |
1.9% |
| Antipyresis |
1.8% |
| Conjunctivitis |
1.8% |
| Eczema |
1.8% |
| Haemorrhagic Diathesis |
1.8% |
|
| Staphylococcal Sepsis |
17.9% |
| Pulmonary Embolism |
10.3% |
| Thrombocytopenia |
7.7% |
| Deafness Unilateral |
5.1% |
| Nephrogenic Systemic Fibrosis |
5.1% |
| Pain |
5.1% |
| Plasma Cell Myeloma |
5.1% |
| Rectal Prolapse |
5.1% |
| Sepsis |
5.1% |
| Ventricular Tachycardia |
5.1% |
| Weight Increased |
5.1% |
| Abdominal Pain |
2.6% |
| Acute Respiratory Distress Syndrome |
2.6% |
| Arthralgia |
2.6% |
| Blood Alkaline Phosphatase Increased |
2.6% |
| Breast Cancer Metastatic |
2.6% |
| C-reactive Protein Increased |
2.6% |
| Cardiac Arrest |
2.6% |
| Cervical Spinal Stenosis |
2.6% |
| Cystitis |
2.6% |
|
| Interacting |
| Mineral Supplementation |
20.9% |
| Ventricular Arrhythmia |
20.9% |
| General Anaesthesia |
14.0% |
| Cardiac Output Decreased |
7.0% |
| Heart Rate Decreased |
7.0% |
| Poor Peripheral Circulation |
7.0% |
| Positive Cardiac Inotropic Effect |
7.0% |
| Torsade De Pointes |
7.0% |
| Ventricular Tachycardia |
7.0% |
| Hypoaesthesia Oral |
2.3% |
|
| Toxicity To Various Agents |
55.6% |
| Neurotoxicity |
33.3% |
| Tooth Disorder |
11.1% |
|
